Reaction
Therapeutic Product Effective For Unapproved Indication reporting signals
As of the last recalculation, Therapeutic Product Effective For Unapproved Indication appears in 360 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is VIGABATRIN (PRR 40.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vigabatrin | 10 | 40.8 | 40.8 |
| Zonisamide | 10 | 40.2 | 40.2 |
| Naproxen Sodium Tablet | 26 | 30.5 | 30.5 |
| Cannabidiol | 10 | 25.4 | 25.4 |